Broadfin Capital’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-505,900
| Closed | -$2.25M | – | 37 |
|
|
2019
Q3 | $2.25M | Sell |
505,900
-241,600
| -32% | -$1.07M | 0.42% | 34 |
|
|
2019
Q2 | $2.89M | Sell |
747,500
-731,743
| -49% | -$2.83M | 0.63% | 31 |
|
|
2019
Q1 | $5.61M | Sell |
1,479,243
-2,746,834
| -65% | -$10.4M | 1.16% | 29 |
|
|
2018
Q4 | $10.1M | Sell |
4,226,077
-237,752
| -5% | -$568K | 1.33% | 18 |
|
|
2018
Q3 | $27.7M | Buy |
4,463,829
+1,214,000
| +37% | +$7.54M | 4.08% | 4 |
|
|
2018
Q2 | $14.7M | Buy |
3,249,829
+2,529,300
| +351% | +$11.4M | 2.31% | 15 |
|
|
2018
Q1 | $3.31M | Sell |
720,529
-381,671
| -35% | -$1.76M | 0.52% | 41 |
|
|
2017
Q4 | $3.54M | Buy |
+1,102,200
| New | +$3.54M | 0.58% | 34 |
|
|
2017
Q3 | – | Sell |
-681,346
| Closed | -$2.52M | – | 44 |
|
|
2017
Q2 | $2.52M | Sell |
681,346
-347,326
| -34% | -$1.29M | 0.31% | 38 |
|
|
2017
Q1 | $5.02M | Sell |
1,028,672
-84,621
| -8% | -$413K | 0.61% | 32 |
|
|
2016
Q4 | $5.7M | Hold |
1,113,293
| – | – | 0.63% | 39 |
|
|
2016
Q3 | $8.06M | Hold |
1,113,293
| – | – | 0.72% | 42 |
|
|
2016
Q2 | $6.62M | Buy |
1,113,293
+149,100
| +15% | +$887K | 0.64% | 38 |
|
|
2016
Q1 | $7.8M | Hold |
964,193
| – | – | 0.75% | 32 |
|
|
2015
Q4 | $7.78M | Hold |
964,193
| – | – | 0.48% | 51 |
|
|
2015
Q3 | $8.06M | Hold |
964,193
| – | – | 0.45% | 49 |
|
|
2015
Q2 | $8.93M | Hold |
964,193
| – | – | 0.48% | 43 |
|
|
2015
Q1 | $9.45M | Buy |
964,193
+575,000
| +148% | +$5.63M | 0.74% | 36 |
|
|
2014
Q4 | $4.35M | Buy |
+389,193
| New | +$4.35M | 0.38% | 55 |
|